{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:11:29Z","timestamp":1788343889039,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jtha.2024.08.015","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T16:51:58Z","timestamp":1725987118000},"page":"3383-3388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Low von Willebrand factor\u2014unraveling an enigma wrapped in a conundrum"],"prefix":"10.1016","volume":"22","author":[{"given":"James S.","family":"O\u2019Donnell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross I.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdows","family":"Atiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.08.015_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-024-00536-8","article-title":"von Willebrand disease","volume":"10","author":"Seidizadeh","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2024.08.015_bib2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1182\/blood-2018-09-874636","article-title":"Increased galactose expression and enhanced clearance in patients with low von Willebrand factor","volume":"133","author":"Aguila","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.015_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bjh.16681","article-title":"New developments in von Willebrand disease","volume":"191","author":"Fogarty","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.08.015_bib4","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"Ward","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.015_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1182\/bloodadvances.2022007340","article-title":"Enhanced VWF clearance in low VWF pathogenesis: limitations of the VWFpp\/VWF:Ag ratio and clinical significance","volume":"7","author":"Doherty","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.08.015_bib6","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/blood-2014-06-528406","article-title":"von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends","volume":"125","author":"Lenting","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.015_bib7","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.08.015_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.15565","article-title":"von Willebrand factor clearance - biological mechanisms and clinical significance","volume":"183","author":"O'Sullivan","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.08.015_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.08.015_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.08.015_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/a-1980-8198","article-title":"Low von Willebrand disease: a bleeding disorder of unknown cause?","volume":"43","author":"O'Donnell","year":"2023","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.jtha.2024.08.015_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/aob.2017.12.05","article-title":"Von Willebrand disease in the United States: perspective from the Zimmerman program","volume":"3","author":"Flood","year":"2018","journal-title":"Ann Blood"},{"key":"10.1016\/j.jtha.2024.08.015_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.015_bib14","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/blood.2020009999","article-title":"von Willebrand factor antigen levels are associated with burden of rare nonsynonymous variants in the VWF gene","volume":"137","author":"Sadler","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.015_bib15","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/bloodadvances.2020002038","article-title":"Low VWF: insights into pathogenesis, diagnosis, and clinical management","volume":"4","author":"O'Donnell","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.08.015_bib16","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2006.01823.x","article-title":"Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD","volume":"4","author":"Eikenboom","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.08.015_bib17","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.015_bib18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/bloodadvances.2019000992","article-title":"Low VWF levels in children and lack of association with bleeding in children undergoing tonsillectomy","volume":"4","author":"Gill","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.08.015_bib19","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2017-05-786699","article-title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","volume":"130","author":"Lavin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.015_bib20","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/bloodadvances.2018017418","article-title":"Significant gynecological bleeding in women with low von Willebrand factor levels","volume":"2","author":"Lavin","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.08.015_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/hae.13881","article-title":"An international survey to inform priorities for new guidelines on von Willebrand\u00a0disease","volume":"26","author":"Kalot","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.08.015_bib22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.08.015_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1046\/j.1351-8216.2003.00832.x","article-title":"Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States","volume":"10","author":"Kirtava","year":"2004","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.08.015_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/bloodadvances.2021005430","article-title":"von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis","volume":"6","author":"Kalot","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.08.015_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14465","article-title":"The 2021 von Willebrand disease guidelines: clarity and controversy","volume":"28","author":"Makris","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.08.015_bib26","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/hae.14528","article-title":"Response to \"The 2021 von Willebrand disease guidelines: Clarity and controversy\"","volume":"28","author":"James","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2024.08.015_bib27","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/asheducation-2009.1.106","article-title":"Low von Willebrand factor: sometimes a risk factor and sometimes a disease","author":"Sadler","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2024.08.015_bib28","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood.2023022457","article-title":"Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies","volume":"143","author":"Atiq","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.08.015_bib29","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1538-7836.2004.00933.x","article-title":"Slippery criteria for von Willebrand disease type 1","volume":"2","author":"Sadler","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.08.015_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2018-10-844936","article-title":"How I treat low von Willebrand factor levels","volume":"133","author":"Lavin","year":"2019","journal-title":"Blood"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624005014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624005014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T06:22:36Z","timestamp":1732947756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624005014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1538783624005014"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.08.015","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low von Willebrand factor\u2014unraveling an enigma wrapped in a conundrum","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}